Company Directory / research
PrivateFor profitresearchBasel, Switzerland
Nouscom
Nouscom is a biotech company working to develop a series of immunotherapeutics capable of selectively killing tumor cells.
- Founded
- 2015 11 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $129M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
11 years old.
Reach
Website ranked #7,397,160 in the world for traffic, about 783 visits a month.
What it does
BiotechnologyGeneticsHealth CareTherapeutics
Funding, as listed
$129M currency not stated
- Rounds4
- LatestSeries c, Mar 2024
- Investors13, 6 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Nouscom, field by field. Contact details are held but never shown.
The company
- Name
- Nouscom
- Type
- For profit
- Status
- Private
- Founded
- 2015
- Founders
- Cinzia Traboni, Elisa Scarduelli, Riccardo Cortese
- Industry
- research
- Categories
- Biotechnology, Genetics, Health Care, Therapeutics
Where
- City
- Basel
- Country
- Switzerland
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #7,397,160
- Monthly web visits
- 783
Funding, as listed
- Total
- 128,500,000 (currency not stated)
- Rounds
- 4
- Latest round
- Series c
- Latest round date
- Mar 2024
- Investors
- 13
- Lead investors
- 6
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Nouscom may be growing as it has recently secured an extended Series C financing round amounting to €75.8 million, which is approximately $82 million. This substantial investment indicates a strong financial backing and confidence from investors in the company's potential within the biotechnology and health care industry. Furthermore, the funds are earmarked for the development of off-the-shelf and personalized cancer vaccines, suggesting an expansion of Nouscom's product pipeline and potentially increasing its market presence in the therapeutics sector.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Switzerland.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,795 companies in Switzerland and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.